PATENT CLAIM ANALYSIS

Application Number: 15863076
Application Type: Utility
Filing Date: 2018-01
Publication Date: 2018-07
Patent Classification: ["424", "204100"]

Abstract:
Provided herein are methods and related compositions for administering viral vectors and synthetic nanocarriers comprising an immunosuppressant. In some embodiments, the methods and compositions provided herein achieve improved transgene expression and/or immune response reduction, such as downregulated IgM and/or IgG immune responses.

Claim (Index 12):
The method of  claim 11 , wherein administration of the pre-dose(s) and/or post-dose(s) occurs within 1 week prior or subsequent to, respectively, to a coadministration.

Metadata:
- Claim Count in Document: 50.0
- Percentile: 86.0
- Lexical Diversity: 1.24324
- Patent Class: 424.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['14846964', '14846967', '14269047', '14802260', '14269056']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7579164662845509
- 35 USC 102 Novelty (BERT): 0.5910746350476133
- Combined Prediction Score: 0.7412322831608572
- Mean Citation Score: 368.570116
- Max Citation Score: 442.11313
- Similarity Product: 272.25938932057977

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test